GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Argenica Therapeutics AGN.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.11

—

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Argenica Therapeutics — daily ASX:AGN

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Argenica Therapeutics on TradingView ↗
Market value
A$14.1m
Last close × shares
Volume
9.6k
Shares, 9 Nov 2026

About Argenica Therapeutics

Its shares trade on ASX under the ticker AGN.AX. It has been listed since 11 June 2021. In the fiscal year to 30 June 2025, it reported revenue of A$512,800 and a net loss of A$7.2m. At that date it held total assets of A$11.0m and shareholders' equity of A$7.2m.

Argenica Therapeutics Ltd. provides neuroprotective treatment. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2021-06-11. The firm is focused on developing therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The firm's lead candidate, ARG-007, is a cationic arginine-rich peptide that aims to protect brain cells and reduce cell death following a stroke, and other types of neural injury, in order to minimize the impact of these conditions and improve patient recovery. ARG-007 has been successfully demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischaemic encephalopathy (HIE).

Figures and description from our data supplier, not checked against the company's own report.

More about Argenica Therapeutics →

Latest on Argenica Therapeutics

Our reporting

We have not reported on Argenica Therapeutics yet.

Next results

2 Mar 2027

Due on 2 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Argenica Therapeutics's ticker?

Argenica Therapeutics trades as AGN.AX on ASX, under ISIN AU0000150328.

What was Argenica Therapeutics's last closing price?

0.11 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Argenica Therapeutics next report results?

Results are expected on 2 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.